Wellcome and the Bill & Melinda Gates Foundation announce US$550 million funding to advance a TB vaccine candidate, M72/AS01E, through a Phase III clinical trial that could be the first in 100 years if proven effective.

The information notes complement the updated WHO guidelines and operational handbook on the management of TB in children and adolescents released in 2022.

Community Advisory Boards representing Africa, Asia-Pacific, and Eastern Europe and Central Asia will ensure research is needs-driven and new tools are accessible.

The Key Asks outline the top priorities the TB community is requesting member states to include in the Political Declaration which is expected to be endorsed by Heads of State during the UN High-Level Meeting on TB in September.

The UN General Assembly will hold the second High-Level Meeting on TB on 22 September 2023. The application process for special accreditation to attend the meeting is now open. The deadline for registration is 19 June 2023.

The signing of the Political Declaration in September will set the agenda for the TB response for the coming five years.

TB Europe Coalition publication: Why is the multisectoral accountability framework to end TB (MAF-TB) so important in the fight against TB and what audiences should be engaged in its launch?

A Multi-stakeholder hearing on TB was held on 8 May 2023 in order to provide an opportunity for all relevant stakeholders to contribute to the ongoing preparatory process for the upcoming UN High-Level Meeting on TB in September.

The Multi-stakeholder hearing on TB will be held on 8 May 2023, providing an opportunity for all relevant stakeholders to contribute to the ongoing preparatory process for the upcoming UN High-Level Meeting on TB.

The joint statement calls on Member States, partners, international agencies, and communities to join forces to collectively drive a response that matches the scale of the TB epidemic.